Paper39677297
Erhong Jiangzhi Decoction Inhibits Lipid Accumulation and Alleviates Nonalcoholic Fatty Liver Disease with Nrf2 Restoration Under Obesity.
Li F and 3 others. J Inflamm Res, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Erhong Jiangzhi Decoction Inhibits Lipid Accumulation and Alleviates Nonalcoholic Fatty Liver Disease with Nrf2 Restoration Under Obesity. Papers, record 39677297. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39677297
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Erhong Jiangzhi Decoction Inhibits Lipid Accumulation and Alleviates Nonalcoholic Fatty Liver Disease with Nrf2 Restoration Under Obesity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28257063 | Red Yeast Rice. | Foods | 2017 | https://conductscience.org/library/papers/28257063 | PubMed |
| 2 | 31913745 | SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity. | Autophagy | 2020 | https://conductscience.org/library/papers/31913745 | PubMed |
| 3 | 28930295 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. | Nat Rev Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/28930295 | PubMed |
| 4 | 33204402 | Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFκB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33204402 | PubMed |
| 5 | 29499228 | Nrf2-Keap1 signaling in oxidative and reductive stress. | Biochim Biophys Acta Mol Cell Res | 2018 | https://conductscience.org/library/papers/29499228 | PubMed |
| 6 | 31558861 | Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31558861 | PubMed |
| 7 | 32976958 | Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. | Toxicology | 2020 | https://conductscience.org/library/papers/32976958 | PubMed |
| 8 | 30950217 | Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30950217 | PubMed |
| 9 | 33977953 | Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. | Food Funct | 2021 | https://conductscience.org/library/papers/33977953 | PubMed |
| 10 | 31195981 | miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. | Mol Med | 2019 | https://conductscience.org/library/papers/31195981 | PubMed |
| 11 | 29967350 | Mechanisms of NAFLD development and therapeutic strategies. | Nat Med | 2018 | https://conductscience.org/library/papers/29967350 | PubMed |
| 12 | 34653601 | Copper (Cu) induced changes of lipid metabolism through oxidative stress-mediated autophagy and Nrf2/PPARγ pathways. | J Nutr Biochem | 2022 | https://conductscience.org/library/papers/34653601 | PubMed |
| 13 | 37192552 | Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/37192552 | PubMed |
| 14 | 35078487 | Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice. | Chin Med | 2022 | https://conductscience.org/library/papers/35078487 | PubMed |
| 15 | 33747104 | Rhodiola rosea L. Attenuates Cigarette Smoke and Lipopolysaccharide-Induced COPD in Rats via Inflammation Inhibition and Antioxidant and Antifibrosis Pathways. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/33747104 | PubMed |
| 16 | 29717933 | The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. | Physiol Rev | 2018 | https://conductscience.org/library/papers/29717933 | PubMed |
| 17 | 35901940 | Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35901940 | PubMed |
| 18 | 30414863 | Non-alcoholic fatty liver disease - A global public health perspective. | J Hepatol | 2019 | https://conductscience.org/library/papers/30414863 | PubMed |
| 19 | 36506575 | Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36506575 | PubMed |
| 20 | 33576035 | Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway. | Hepatology | 2021 | https://conductscience.org/library/papers/33576035 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40862425 | Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway. | Acta Cir Bras | 2025 | https://conductscience.org/library/papers/40862425 |
Source PubMed
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39677297
GET https://conductscience.org/api/papers/v1/39677297/references?page=2